First Look: The 2026 Biotech AI Report
An exclusive first readout of what biotech leaders need to know heading into JPM — and how 100 AI frontrunners are translating AI into real scientific impact
Get a rare, upfront look at what the most advanced biotech teams are actually doing with AI. See where AI is delivering measurable gains today, where it is stalling out, and what this means for organizations preparing for automation, multimodal models, and closed-loop systems. Register today and you’ll be among the first to receive the full report when it launches.
Where AI is already delivering real gains today: New data on speed, hit-rate lift, and where AI works best across research and development.
Why AI hits a wall in complex science: The “clean-data ceiling” and how leaders are reworking infrastructure to break through it.
The next wave of AI in biotech: How teams are preparing for multimodal models, autonomous agents, and AI-ready lab automation.
Tech maturity as the new R&D KPI: Why 2026 is the year technical infrastructure matters as much as pipeline.
An inside view of AI-native science in action: Insights from working with Benchling customers, deploying AI copilots and agents, and building the underlying platform for AI-native science.
Register now
You're registered
Thank you for registering. We'll email you a calendar invite along with the details.
